Literature DB >> 6732421

Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses.

C Siegel, M Waldo, G Mizner, L E Adler, R Freedman.   

Abstract

A deficit in inhibitory gating of auditory evoked responses was examined in 15 schizophrenic patients, their first-degree relatives, and normal subjects, using a conditioning-testing paradigm with the P50 wave of the auditory evoked response. This paradigm demonstrates inhibition by presenting paired stimuli to the subject; the P50 wave evoked by the second stimulus is reduced because of inhibitory mechanisms activated during the response to the first stimulus. In normal subjects, the mean amplitude of the second P50 response was reduced to less than 20%. In the schizophrenics, the mean amplitude of the second response was more than 85% of the first, a result that replicates our previous finding of a deficit in inhibition in schizophrenia. Approximately half the first-degree relatives, generally including at least one parent, had a similar deficit. Presence of this deficit in the parents was associated with a family history of schizophrenia. Family members with this deficit also had significantly higher scores on several scales of the Minnesota Multiphasic Personality Inventory than did family members without the deficit. Despite the deficit in inhibition, other characteristics of the P50 wave were normal in the relatives, in contrast to unmedicated schizophrenics, who showed additional abnormalities in wave latency and amplitude.

Entities:  

Mesh:

Year:  1984        PMID: 6732421     DOI: 10.1001/archpsyc.1984.01790170081009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  73 in total

Review 1.  The genetics of sensory gating deficits in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Randall G Ross; Merilyne C Waldo; Karen E Stevens; Lawrence E Adler; Sherry Leonard
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

2.  Mapping repetition suppression of the N100 evoked response to the human cerebral cortex.

Authors:  Nash N Boutros; Klevest Gjini; Horst Urbach; Mark E Pflieger
Journal:  Biol Psychiatry       Date:  2011-01-28       Impact factor: 13.382

Review 3.  Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?

Authors:  Craig M Powell; Tsuyoshi Miyakawa
Journal:  Biol Psychiatry       Date:  2006-06-15       Impact factor: 13.382

4.  Towards a functional topography of sensory gating areas: invasive P50 recording and electrical stimulation mapping in epilepsy surgery candidates.

Authors:  Martin Kurthen; Peter Trautner; Timm Rosburg; Thomas Grunwald; Thomas Dietl; Kai-Uwe Kühn; Carlo Schaller; Christian E Elger; Horst Urbach; Kost Elisevich; Nash N Boutros
Journal:  Psychiatry Res       Date:  2007-05-21       Impact factor: 3.222

Review 5.  Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.

Authors:  David Potter; Ann Summerfelt; James Gold; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

6.  Failure to find P50 suppression deficits in young first-episode patients with schizophrenia and clinically unaffected siblings.

Authors:  O M de Wilde; L J Bour; P M Dingemans; J H T M Koelman; D H Linszen
Journal:  Schizophr Bull       Date:  2007-02-07       Impact factor: 9.306

Review 7.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

8.  Juvenile exposure to ketamine causes delayed emergence of EEG abnormalities during adulthood in mice.

Authors:  R E Featherstone; L R Nagy; C G Hahn; S J Siegel
Journal:  Drug Alcohol Depend       Date:  2013-09-27       Impact factor: 4.492

9.  Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.

Authors:  Erin A Hazlett; Ethan G Rothstein; Rui Ferreira; Jeremy M Silverman; Larry J Siever; Ann Olincy
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

Review 10.  Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.